Profile of Mecasermin for the Long-Term Treatment of Growth Failure in Children and Adolescents With Severe Primary IGF-1 Deficiency
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s6178
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2009
Authors
Publisher
Informa UK Limited